CAS: 1187-58-2; N-Methylpropionamide

该化合物是分子式C4H9NO的极性蛋白溶剂,对有温味,水中不易吸附和许多有机溶剂的黄色液体无色,该化合物具有高热稳定性和广度液体,适合需要受控反应条件的应用.其氨化功能允许其在有机合成中充当溶剂或中间剂,特别是在浸泡物混合和制药中.N-甲基丙酰胺的低挥发性和对水解的耐受性提高了其在高温过程中的效用.由于它有利的电化学特性,它还被用于电化学应用中.

结构式图片

相似化合物

79-05-0 6330-25-2 758-96-3

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号74-89-5 氨基甲烷 | CAS号79-03-8 丙酰氯 | CAS号1719-57-9 氯甲基二甲基氯硅烷 | CAS号79-05-0 丙酰胺 | CAS号96-29-7 2-丁酮肟 | CAS号10341-59-0 (Z)-2-Butanone oxime | CAS号54509-73-8 ethene | CAS号85462-16-4 N-Methyl-O-p-ni... | CAS号71-23-8 正丙醇 | CAS号74-89-5 氨基甲烷 | CAS号627-35-0 N-甲基正丙胺 | CAS号32150-22-4 methyl N-methyl... | CAS号16395-80-5 N-methyl-N-nitr... | CAS号90910-85-3 zinc,N-methylpr...

合成工艺路线路线简述

    氯甲基二甲基氯硅烷,丙酰胺置于六甲基二硅氮烷,Cesium Fluoride体系中,用 乙腈 用作溶剂,化学反应 48.0H,以82%的收率获得n-甲基丙酰胺
    参考文献:使用氯甲基二甲基氯硅烷对酰胺和杂环进行化学选择性甲基化
    标题:使用氯甲基二甲基氯硅烷对酰胺和杂环进行化学选择性甲基化
    摘要:氯甲基二甲基甲硅烷基氯与酰胺的反应生成五配位的n-(氨基甲基)-卤代硅烷,其可以被氟化铯脱甲硅烷基化而得到n-甲基酰胺.这提供了在其他更多亲核基团存在下酰胺单烷基化的选择性方法.
    Doi:10.1016/s0040-4039(00)00731-0

    海关参考信息

    专利信息


    专利号:US-6815214-B2
    优先权日:2000-12-29
    标 题 :Pharmaceutical uses and synthesis of diketopiperazines
    发明人:BOYCE JIM P; HOWBERT J JEFFRY; TABONE JOHN C
    权利人:CELLTECH R & D INC
    摘要:The synthesis of novel diketopiperazines, their use in inhibiting cellular events such as those involving NFK-α, NFK-β and in the treatment of inflammation events, a combinatorial library of diverse diketopiperazines and process for their synthesis as a library and as individual compounds. In particular novel diketopiperazines are disclosed including their synthesis and use in cellular events such as activation of the transcription factor, nuclear factor, TNF-α, TNF-β and also apoptosis.

    专利号:US-4898952-A
    优先权日:1987-05-29
    标 题 :Regioselective synthesis of a 1,5-disubstituted pyrazole
    发明人:MURRAY WILLIAM V; WACHTER MICHAEL P
    权利人:ORTHO PHARMA CORP
    摘要:A highly regioselective synthesis of pyrazoles from a mono-substituted hydrazine and a beta -dicarbonyl compound wherein a carboxylic acid moiety is present on the substituent attached to one of the carbonyls. For example, compounds of the formula (I) are formed in marked preference to isomers of formula (IV): (I) (IV)

    专利号:US-10882884-B2
    优先权日:2016-05-18
    标题:Stereoselective synthesis of phosphorothioate oligoribonucleotides
    发明人:HALL JONATHAN; LI MEILING
    权利人:ETH ZUERICH
    摘要:The present invention relates to chiral phosphoramidites represented by formula (Ia) or formula (Ib) n n n n n n n n n n n n as novel monomers for the synthesis of stereodefined phosphorothioate MOE oligonucleotides. Furthermore, the present invention relates to a method for synthesizing stereodefined phosphorothioate MOE oligonucleotides using said novel chiral phosphoramidites.

    专利号:WO-2024163644-A1
    优先权日:2023-02-01
    标题:Belt reactor manufacturing process for oligomer synthesis
    发明人:KELLER KARSTEN; HILLEBRAND ROMAN
    权利人:ARROWHEAD PHARMACEUTICALS INC
    摘要:A method and apparatus for synthesis of oligomers such as oligonucleotides and peptides are disclosed. The method employs a device including at least one deprotection station to carry out a step of deprotection, at least one coupling station to carry out a step of coupling, optionally, one or more oxidation and/or thiolation stations to carry out a step of oxidation or thiolation, optionally, one or more capping stations to carry out a step of capping, and, optionally, one or more washing stations to carry out a step of washing. A plurality of solid phase material for oligomer synthesis is moved to the stations via a conveyor device, wherein a fluid delivery device acts upon said solid phase material to produce an oligomer.

    专利号:US-6492136-B1
    优先权日:1995-12-07
    标题 :Solid phase organic synthesis
    发明人:FLITSCH SABINE LAHJA; TURNER NICHOLAS JOHN
    权利人:GENZYME LTD
    摘要:A method of synthesis of a material corresponding to the general formula:characterized in that it comprises a material corresponding to the following general formula:being cleaved as indicated enzymatically or non-enzymatically using acid catalysis in the presence of a nucleophile, wherein: R1 represents a group providing the site for exo-enzyme or acid hydrolysis; R2 represents an intermediate linked to a solid support; R3 represents a carbohydrate, (oligo-)saccharide, (glyco-)peptide, (glyco-)lipid or an organic molecule which is at least one of heterocyclic and aromatic in structure; X represents O, N(H), N(R''), C(O)O, S, C(O)N(H) or C(O)N(R''), R'' being a non-interfering group; and Support represents a solid support.

    专利号:US-7329760-B2
    优先权日:2002-04-05
    标题 :CC-1065 analog synthesis
    发明人:ZHAO ROBERT YONGXIN; CHARI RAVI V J
    权利人:IMMUNOGEN INC
    摘要:Improved synthesis of seco(−)CBI (5-hydroxy-3-amino-1-[S]-(chloromethyl)-1,2-dihydro-3H-benz(e)indole): n nand improved syntheses therefrom of a wide variety of CC-1065 analogs that comprise a cyclopropabenzidole (CBI) alkylating moiety, and which are collectively DC1 and its derivatives, for the synthesis of cell-targeted therapeutic agents.
    玉门千华制药有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.tianhuachem.com
    企业联系电话:0519-82891186;82618618;82618688👤
    📞玉门千华制药有限公司 ⚠️参考联系方式
    联系人:李剑平
    电话:0519-82891186;82618618;82618688
    手机:13358197316
    传真:0519-82899734
    邮箱:tianhua@tianhuachem.com
    通信地址: 甘肃省酒泉市玉门市老市区化工园区三八路8号
    邮编: 213200
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:甘肃省酒泉市玉门市老市区化工园区三八路8号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Zirconium-Hydride-Catalyzed Site-Selective Hydroboration Of Amides For The Synthesis Of Amines: Mechanism, Scope, And Application
    作者:Bo Han,Jiong Zhang,Haijun Jiao,Lipeng Wu |发布日期:2021.11
    摘要:Diverse Amines. Various Readily Reducible Functional Groups, Such As Esters, Alkynes, And Alkenes, Were Well Tolerated. Furthermore, The Methodology Was Extended To The Synthesis Of Bio- And Drug-Derived Amines. Detailed Mechanistic Studies Revealed A Reaction Pathway Entailing Aldehyde And Amido Complex Formation Via An Unusual C-N Bond Cleavage-Reformation Process, Followed By C-O Bond Cleavage.

    合成参考文献


    摘要:Grimmer, J.; Krieg, S.-C.; Manolikakes, G., Science of Synthesis Knowledge Updates, (2021) 1, 241.
    摘要:Besson, M.; Pinel, C., Science of Synthesis: Catalytic Reduction in Organic Synthesis, (2017) 2, 281.
    摘要:Huang, J.; Ma, D., Science of Synthesis: Special Topics, (2022) 1, 15.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知